(USD) | Sep 2023 | Q/Q |
---|---|---|
Revenue | 19.5MM | -16% |
Gross Profit | 10MM | -20% |
Cost Of Revenue | 9.5MM | -10% |
Operating Income | -9.4MM | +32% |
Operating Expenses | 19.4MM | -2% |
Net Income | -14.8MM | +56% |
R&D | 2.5MM | +4% |
G&A | 7.6MM | +4% |
Marketing | 9.3MM | -7% |
Amortization | 1MM | +11% |
Interest Expense | 2.4MM | -6% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Company secures $22.5 million of new money in debtor-in-possession financing from existing lenders to support ongoing operations during the sale processIRVINE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company developing and commercializing safe and innovative solutions for the best aesthetic outcomes, announced that it filed for Chapter 11 protection in the United States Bankruptcy Court for the District of Delawar
In this article, we will be taking a look at the 20 countries with the highest plastic surgery rates per capita. if you are not interested in learning about transforming trends and the global surge in cosmetic surgeries, head straight to the 5 Countries With The Highest Plastic Surgery Rates Per Capita. Global Surge in […]
Sientra, Inc. (NASDAQ:SIEN) Q3 2023 Earnings Call Transcript November 9, 2023 Sientra, Inc. misses on earnings expectations. Reported EPS is $-1.31 EPS, expectations were $-0.48. Operator: Good afternoon and welcome to the Sientra Third Quarter 2023 Financial Results Conference Call. My name is Dave. At this time, all participants are in a listen-only mode. After […]
Q3 2023 Sientra Inc Earnings Call
IRVINE, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company developing the safest and most innovative solutions for the best aesthetic outcomes, today announced its financial results for the third quarter that ended September 30, 2023. Third Quarter 2023 Financial and Business Highlights Net sales of $19.5 million representing a decrease of 13.7% over the third quarter of 2022. For the first nine months of 2023, net s
IRVINE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company developing the safest and most innovative solutions for the best aesthetic outcomes, today announced its participation at the Stifel 2023 Healthcare Conference. As part of the conference, the company’s management team will participate in a live fireside chat on Wednesday, November 15, 2023 at 8:00am EST / 5:00am PST. An on-demand webcast of the presentation w
IRVINE, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company delivering the safest and most innovative solutions for the best outcomes, today announced preliminary unaudited financial results for the fiscal third quarter ended September 30, 2023. Total unaudited revenue for the third quarter of 2023 is expected to be in the range of $19.2 million to $19.7 million, compared to total revenue of $22.6 million in the prior
The best short-squeeze stocks to buy now can be a perilous territory in the investment landscape. However, they also possess the potential for astronomical returns. At the heart of this phenomenon is a strategic psychological game. When investors dive into heavily shorted securities, they’re not merely making a casual bet; they’re essentially trying to ignite a panic among those who are betting against the stock. Here’s how it works: short-sellers borrow shares they don’t own and sell them on th
In this article, we discuss 10 best cosmetic surgery and aesthetics stocks to buy. If you want to skip our detailed discussion on the cosmetics and aesthetics sector, head directly to 5 Best Cosmetic Surgery and Aesthetics Stocks to Buy. The American Society of Plastic Surgeons noted that numerous celebrities adopted a perspective favoring larger […]
Here is how Ambrx Biopharma Inc. Sponsored ADR (AMAM) and Sientra (SIEN) have performed compared to their sector so far this year.